Rivas Alonso Verónica, Flores Rivera José de Jesús, Rito García Yamel, Corona Teresa
Clinical Laboratory of Neurodegenerative Diseases, National Institute of Neurology and Neurosurgery "Dr Manuel Velasco Suárez", México.
Mult Scler J Exp Transl Clin. 2017 Sep 25;3(3):2055217317727295. doi: 10.1177/2055217317727295. eCollection 2017 Jul-Sep.
In today's globalised world, the heterogeneity of diseases such as multiple sclerosis has been studied since it has been suggested that ethnic differences, in conjunction with geographical and environmental factors, influence its incidence and prevalence.
Based on this, an attempt has been made to identify the genetic factors that may confer risk or protection, not only for developing multiple sclerosis but also for determining the course of its evolution.
In Latin America we have some data about this, which have been replicated in different populations in the entire region, with very different results compared with other regions, which could explain not only the different frequencies in some populations, such as Caucasians, but also the course of the disease and the response to actual treatments. However, in addition to these findings, other associated epigenetic mechanisms have also been found in our populations, such as levels of vitamin D, parasitic diseases, and indigenous populations. Therefore, the study of epigenetics plays a crucial role in understanding the physiopathology of multiple sclerosis. It must be studied in each population, especially in Latin America, due to its broad heterogeneity.
It is very important to understand not only the genetic and external factors with these very specific effects in multiple sclerosis patients, but also the way they interact and are able to explain the frequency and some specific phenotypes of the disease in our populations besides the posibility to be a very specific treatment target.
在当今全球化的世界中,由于有人提出种族差异与地理和环境因素共同影响多发性硬化症等疾病的发病率和患病率,因此对其异质性进行了研究。
基于此,人们试图确定不仅可能导致患多发性硬化症风险或提供保护,而且还能决定其演变过程的遗传因素。
在拉丁美洲,我们有关于此的一些数据,这些数据已在该地区不同人群中得到重复验证,与其他地区相比结果差异很大,这不仅可以解释某些人群(如白种人)中不同的发病率,还能解释疾病的进程以及对现有治疗的反应。然而,除了这些发现之外,我们的人群中还发现了其他相关的表观遗传机制,如维生素D水平、寄生虫病和原住民。因此,表观遗传学研究在理解多发性硬化症的生理病理学方面起着至关重要的作用。由于拉丁美洲人群具有广泛的异质性,必须在每个群体中进行研究,尤其是在拉丁美洲。
不仅要了解对多发性硬化症患者有这些非常特殊影响的遗传和外部因素,还要了解它们相互作用的方式,以及它们除了可能成为非常特殊的治疗靶点之外,还能够解释我们人群中疾病的发病率和一些特定表型,这一点非常重要。